Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

57.09
+3.095.72%
Post-market: 57.090.00000.00%19:27 EDT
Volume:1.44M
Turnover:82.12M
Market Cap:8.95B
PE:124.11
High:57.43
Open:54.89
Low:54.31
Close:54.00
52wk High:80.95
52wk Low:46.01
Shares:156.77M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:0.93%
Dividend:0.32
Dividend Rate:0.56%
EPS(TTM):0.4600
EPS(LYR):0.4660
ROE:3.68%
ROA:2.92%
PB:4.66
PE(LYR):122.52

Loading ...

Bio-Techne Corporation and Partners Award $1.025 Million in G-Rex Grants to USC and CHLA for Advancing Cell and Gene Therapy Initiatives

Reuters
·
May 14

Table: G-TECH Optoelectronics 1Q Net Loss NT$146.0M Vs NT$7.48M

Dow Jones
·
May 14

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 14

Table: U-TECH Media 1Q Net Profit NT$13.8M Vs NT$63.6M

Dow Jones
·
May 13

AION-TECH Gets Board Nod to Inject INR30 Million More in Wholly-Owned Subsidiary

MT Newswires Live
·
May 13

Bio-Techne Corp. Stock Rises 7.9%, Outperforms Competitors

Dow Jones
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers Health, TXNM Energy, Forge Global

Reuters
·
May 13

BUZZ-Life sciences firms climb after US and China agree to cut tariffs

Reuters
·
May 12

Bio-Techne Is Maintained at Buy by UBS

Dow Jones
·
May 10

UBS Adjusts Price Target on Bio-Techne to $70 From $95, Maintains Buy Rating

MT Newswires Live
·
May 09

Bio-Techne Collaborates With Genome Engineering Firm Kytopen

MT Newswires Live
·
May 08

Bio-Techne Is Maintained at Hold by Stifel

Dow Jones
·
May 08

Bio-Techne, Kytopen collaborate on integrated cellular engineering workflow

TIPRANKS
·
May 08

Bio-Techne (TECH) Gets a Buy from Benchmark Co.

TIPRANKS
·
May 08

Table: G-TECH Optoelectronics Apr Rev NT$210.5M Vs NT$162.8M

Dow Jones
·
May 08

Bio-Techne’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
May 08

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 08

Evercore ISI Cuts Price Target on Bio-Techne to $60 From $70

MT Newswires Live
·
May 08

Bio-Techne Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Bio-Techne Approves $500 Million Share Buyback Program, Keeps Quarterly Dividend at $0.08 per Share

MT Newswires Live
·
May 07